Cargando…

Metabolic syndrome-associated cognitive decline in mice: Role of minocycline

OBJECTIVE: The objective of the study was to characterize the mechanism associated with metabolic syndrome (MetS)-associated cognitive decline and determine the effect of minocycline on the above condition in mice. MATERIALS AND METHODS: We developed a HFHC diet-induced MetS model in mice. Diagnosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Aniruddha, Mehta, Bina K., Sen, Kalyan K., Banerjee, Sugato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044134/
https://www.ncbi.nlm.nih.gov/pubmed/30100653
http://dx.doi.org/10.4103/ijp.IJP_110_18
_version_ 1783339422529355776
author Mukherjee, Aniruddha
Mehta, Bina K.
Sen, Kalyan K.
Banerjee, Sugato
author_facet Mukherjee, Aniruddha
Mehta, Bina K.
Sen, Kalyan K.
Banerjee, Sugato
author_sort Mukherjee, Aniruddha
collection PubMed
description OBJECTIVE: The objective of the study was to characterize the mechanism associated with metabolic syndrome (MetS)-associated cognitive decline and determine the effect of minocycline on the above condition in mice. MATERIALS AND METHODS: We developed a HFHC diet-induced MetS model in mice. Diagnostic characteristics of MetS including waist circumference, lipid levels, blood pressure, and fasting blood glucose were measured in these Swiss albino mice. Cognitive parameters were measured using passive avoidance and elevated plus maze test. Hippocampal acetylcholine esterase (AchE), reduced glutathione (GSH), and cytokine levels were measured and histopathological evaluation conducted. The MetS animals were administered minocycline (50 mg/kg; 10 days) and the above parameters were measured. RESULTS: We successfully induced MetS using HFHC diet in mice. Animals showed significantly higher fasting blood glucose levels (P < 0.001), systolic blood pressure (P < 0.01), waist circumference (P < 0.001), low-density lipoprotein (P < 0.001), and triglyceride (P < 0.01) and reduced high density lipoprotein levels (P < 0.05) compared to control animals. Both scopolamine and MetS significantly lowered (P < 0.01) step-down latency and increased transfer latency (P < 0.001). MetS animals showed significantly higher AchE (P < 0.001) and tumor necrosis factor-α (P < 0.001) and Interleukin-1 β (P < 0.01) and lower GSH (P < 0.001) levels and reduced both CA1 (P < 0.001) and CA3 (P < 0.01) neuronal density compared to controls. Minocycline treatment partially reversed the above neurobehavioral and biochemical changes and improved hippocampal neuronal density in MetS animals. CONCLUSION: MetS led to hippocampal oxidative stress and neuroinflammatory changes with a corresponding loss of hippocampal neuronal density and cognitive decline. Anti-inflammatory and antioxidant property of minocycline may be responsible for its neuroprotective actions in these animals.
format Online
Article
Text
id pubmed-6044134
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-60441342018-08-10 Metabolic syndrome-associated cognitive decline in mice: Role of minocycline Mukherjee, Aniruddha Mehta, Bina K. Sen, Kalyan K. Banerjee, Sugato Indian J Pharmacol Research Article OBJECTIVE: The objective of the study was to characterize the mechanism associated with metabolic syndrome (MetS)-associated cognitive decline and determine the effect of minocycline on the above condition in mice. MATERIALS AND METHODS: We developed a HFHC diet-induced MetS model in mice. Diagnostic characteristics of MetS including waist circumference, lipid levels, blood pressure, and fasting blood glucose were measured in these Swiss albino mice. Cognitive parameters were measured using passive avoidance and elevated plus maze test. Hippocampal acetylcholine esterase (AchE), reduced glutathione (GSH), and cytokine levels were measured and histopathological evaluation conducted. The MetS animals were administered minocycline (50 mg/kg; 10 days) and the above parameters were measured. RESULTS: We successfully induced MetS using HFHC diet in mice. Animals showed significantly higher fasting blood glucose levels (P < 0.001), systolic blood pressure (P < 0.01), waist circumference (P < 0.001), low-density lipoprotein (P < 0.001), and triglyceride (P < 0.01) and reduced high density lipoprotein levels (P < 0.05) compared to control animals. Both scopolamine and MetS significantly lowered (P < 0.01) step-down latency and increased transfer latency (P < 0.001). MetS animals showed significantly higher AchE (P < 0.001) and tumor necrosis factor-α (P < 0.001) and Interleukin-1 β (P < 0.01) and lower GSH (P < 0.001) levels and reduced both CA1 (P < 0.001) and CA3 (P < 0.01) neuronal density compared to controls. Minocycline treatment partially reversed the above neurobehavioral and biochemical changes and improved hippocampal neuronal density in MetS animals. CONCLUSION: MetS led to hippocampal oxidative stress and neuroinflammatory changes with a corresponding loss of hippocampal neuronal density and cognitive decline. Anti-inflammatory and antioxidant property of minocycline may be responsible for its neuroprotective actions in these animals. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6044134/ /pubmed/30100653 http://dx.doi.org/10.4103/ijp.IJP_110_18 Text en Copyright: © 2018 Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Research Article
Mukherjee, Aniruddha
Mehta, Bina K.
Sen, Kalyan K.
Banerjee, Sugato
Metabolic syndrome-associated cognitive decline in mice: Role of minocycline
title Metabolic syndrome-associated cognitive decline in mice: Role of minocycline
title_full Metabolic syndrome-associated cognitive decline in mice: Role of minocycline
title_fullStr Metabolic syndrome-associated cognitive decline in mice: Role of minocycline
title_full_unstemmed Metabolic syndrome-associated cognitive decline in mice: Role of minocycline
title_short Metabolic syndrome-associated cognitive decline in mice: Role of minocycline
title_sort metabolic syndrome-associated cognitive decline in mice: role of minocycline
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044134/
https://www.ncbi.nlm.nih.gov/pubmed/30100653
http://dx.doi.org/10.4103/ijp.IJP_110_18
work_keys_str_mv AT mukherjeeaniruddha metabolicsyndromeassociatedcognitivedeclineinmiceroleofminocycline
AT mehtabinak metabolicsyndromeassociatedcognitivedeclineinmiceroleofminocycline
AT senkalyank metabolicsyndromeassociatedcognitivedeclineinmiceroleofminocycline
AT banerjeesugato metabolicsyndromeassociatedcognitivedeclineinmiceroleofminocycline